Patents-Review.com
🔗 Permalink
Assignee profile:

SDG, Inc.

City:

Cleveland, Ohio

Country:

United States

Published Applications:

16

Last publication date:

2023-06-08

Patent Grants:

15

Last grant date:

2022-12-06

Top Inventors for applications by SDG, Inc.

These are the the leading inventors for applications assigned to SDG, Inc.:

Recent patent applications by SDG, Inc.

SDG, Inc. based in Cleveland, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2023-06-08
US20230172868A1
Human necessities

LIPID-BASED NANOPARTICLES WITH ENHANCED STABILITY

 #2 | 2020-12-31 ✅ Patent 11,517,529 granted on 2022-12-06
US20200405638A1
Human necessities

Orally bioavailable lipid-based constructs

 #3 | 2020-10-22 ✅ Patent 11,077,173 granted on 2021-08-03
US20200330560A1
Human necessities

Lipid-based nanoparticles and methods using same

 #4 | 2020-10-15 ✅ Patent 10,918,700 granted on 2021-02-16
US20200323961A1
Human necessities

Lipid-based nanoparticles and use of same in optimized insulin dosing regimens

 #5 | 2020-01-23 ✅ Patent 11,071,715 granted on 2021-07-27
US20200022922A1
Human necessities

Lipid-based nanoparticles and methods using same

 #6 | 2019-02-21 ✅ Patent 10,463,616 granted on 2019-11-05
US20190054021A1
Human necessities

Lipid construct for delivery of insulin to a mammal

 #7 | 2015-05-07 ✅ Patent 10,568,835 granted on 2020-02-25
US20150125518A1
Human necessities

Orally bioavailable lipid-based constructs

 #8 | 2015-01-29 ✅ Patent 9,034,372 granted on 2015-05-19
US20150031608A1
Human necessities

Lipid construct for delivery of insulin to a mammal

 #9 | 2014-08-28 ✅ Patent 9,943,602 granted on 2018-04-17
US20140243430A1
Human necessities

Orally bioavailable lipid-based constructs

 #10 | 2013-10-10 ✅ Patent 10,004,686 granted on 2018-06-26
US20130267462A1
Human necessities

Lipid construct for delivery of insulin to a mammal

 #11 | 2013-07-18 ✅ Patent 10,751,418 granted on 2020-08-25
US20130183270A1
Human necessities

Orally bioavailable lipid-based constructs

 #12 | 2011-06-09 ✅ Patent 8,257,735 granted on 2012-09-04
US20110135727A1
Human necessities

Method of increasing the bioavailability of recombinant human insulin isophane in a patient

 #13 | 2010-12-09 ✅ Patent 8,846,053 granted on 2014-09-30
US20100310599A1
Human necessities

Orally bioavailable lipid-based constructs

 #14 | 2010-09-30 ✅ Patent 9,145,453 granted on 2015-09-29
US20100247625A1
Chemistry; metallurgy

Orally bioavailable lipid-based constructs

 #15 | 2010-08-19 ✅ Patent 8,303,983 granted on 2012-11-06
US20100209492A1
Human necessities

Targeted liposomal drug delivery system

 #16 | 2009-04-02 ✅ Patent 8,962,015 granted on 2015-02-24
US20090087479A1
Human necessities

Orally bioavailable lipid-based constructs

Also check out SDG, INC.'s (Cleveland, United States) applicant profile with 12 patent applications submitted.

AssigneeID:

30703 ⎘